404 Not Foundnginx/1.22.0 Financial Fund July 8th The net value of GF Medicines and Healthy Hybrid Securities Investment Fund (abbreviation: GF Medicines and Healthy Mixed C, code 010111) fell by 2.06% on July 7th, attracting investors' attention. The current net value of fund un

404 Not Found

Financial Sector Fund July 8 News The net value of GF Pharmaceutical and Health Hybrid Securities Investment Fund (abbreviation: GF Pharmaceutical and Health Hybrid C, code 010111) fell by 2.06% on July 7, attracting investors' attention. The current net value of fund unit is 0.7361 yuan, and the cumulative net value is 0.7361 yuan.

GF Medical Health Hybrid C Fund has earned -26.39% since its establishment, -15.38% since this year, 13.16% in the past month, and -35.99% in the past year.

This fund has distributed 0 dividends since its establishment, with a cumulative dividend amount of 0 billion yuan. The fund is currently open for subscription. The fund manager of

is Wu Xingwu. He has managed the fund since October 21, 2020, with a return of -24.84% during his tenure. The latest fund periodic report of

shows that the fund holds heavy positions in WuXi AppTec ( holds a holding ratio of 10.22%), Asymlink (a holding ratio of 10.04%), Porton shares (a holding ratio of 9.80%), Zhifei Biologics (position ratio 6.55%), WuXi Biologics (position ratio 6.37%), Tigermed (position ratio 4.10%), Pharmaron (position ratio 3.40%), Pien Tze Huang (position ratio 3.22%) ), Amic (position ratio 3.05%), ProPharmaceutical (position ratio 2.83%).

During the reporting period, Fund Investment Strategy and Operational Analysis

In the first quarter, the market trend was weak, the pharmaceutical sector experienced a large decline, and the net value of the Fund had a large retracement. The

market has adjusted to the current stage. The valuations of some high-quality companies have returned to relatively low positions in the past three years. Many companies whose long-term development logic is affected by policies are now relatively stable. We believe that the price/performance ratio of many assets is already at a relatively low level. appropriate level.

The ability of an enterprise is the most important factor for us, but policy disturbances and changes in economic climate are also important external factors that affect the development of the enterprise. We will consider it comprehensively and strive to find a balance point to create profits.

Fund performance during the reporting period